Dermata Financial Statements From 2010 to 2026

DRMAW Stock  USD 0.02  0.0001  0.52%   
Dermata Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Dermata Therapeutics' valuation are provided below:
Earnings Share
(2.16)
There are over ninety-four available fundamental signals for Dermata Therapeutics Warrant, which can be analyzed over time and compared to other ratios. All traders should should verify Dermata Therapeutics' prevailing fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable.
Check Dermata Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dermata Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 272.6 K, Depreciation And Amortization of 15.1 M or Interest Expense of 111.4 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.13. Dermata financial statements analysis is a perfect complement when working with Dermata Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Dermata Stock
Check out the analysis of Dermata Therapeutics Correlation against competitors.
For more information on how to buy Dermata Stock please use our How to Invest in Dermata Therapeutics guide.

Dermata Therapeutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total AssetsM4.1 M3.6 M
Slightly volatile
Short and Long Term Debt Total2.7 M4.1 M2.2 M
Slightly volatile
Other Current Liabilities758.7 K1.3 M713.6 K
Slightly volatile
Total Current Liabilities1.5 M1.8 M1.8 M
Very volatile
Current Deferred Revenue124 K139.5 K152.3 K
Slightly volatile
Accounts Payable573.4 K929.2 K450.9 K
Slightly volatile
Cash5.5 M3.6 M3.4 M
Slightly volatile
Long Term Debt442.6 K497.9 K543.4 K
Slightly volatile
Cash And Short Term Investments5.5 M3.6 M3.4 M
Slightly volatile
Common Stock Shares Outstanding184.7 K175.9 K40.7 K
Slightly volatile
Liabilities And Stockholders EquityM4.1 M3.6 M
Slightly volatile
Other Current Assets473.3 K428.2 K243.9 K
Slightly volatile
Total Liabilities1.6 M1.8 M2.1 M
Slightly volatile
Net Invested Capital1.7 M1.8 M2.3 M
Slightly volatile
Property Plant And Equipment Gross61.3 K68.9 K75.3 K
Slightly volatile
Short and Long Term Debt2.4 M4.1 M1.9 M
Slightly volatile
Total Current AssetsM4.1 M3.6 M
Slightly volatile
Short Term Debt2.4 M4.1 M1.9 M
Slightly volatile
Common Stock2152271.5 M
Slightly volatile
Capital Stock215227724
Slightly volatile
Net Receivables8.4 K7.5 K11.6 K
Slightly volatile
Short Term Investments2.5 B2.8 B3.1 B
Slightly volatile

Dermata Therapeutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization15.1 M14.4 M2.9 M
Slightly volatile
Interest Expense111.4 K57.2 K182.9 K
Slightly volatile
Selling General Administrative3.7 MM2.7 M
Slightly volatile
Other Operating Expenses8.4 M14.4 M6.4 M
Slightly volatile
Research Development9.9 M9.4 MM
Slightly volatile
Cost Of Revenue275290925
Slightly volatile
Total Operating Expenses8.4 M14.4 M6.4 M
Slightly volatile
Interest Income196.7 K259.6 K103.3 K
Slightly volatile
Selling And Marketing Expenses3.2 B3.6 B3.9 B
Slightly volatile

Dermata Therapeutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow5.2 M8.6 M3.1 M
Slightly volatile
Depreciation17.1 K16.2 K6.1 K
Slightly volatile
Issuance Of Capital StockM7.9 MM
Pretty Stable
Total Cash From Financing Activities7.7 M7.9 M5.9 M
Slightly volatile
End Period Cash Flow5.5 M3.6 M3.4 M
Slightly volatile
Dividends Paid1.8 M2.1 M2.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables440.7 K753.3 K417.1 K
Slightly volatile
Payables Turnover0.00390.00360.0037
Slightly volatile
Cash Per Share22.5823.76391
Slightly volatile
Days Payables Outstanding83.6 K106.4 K99.4 K
Slightly volatile
Income Quality1.01.040.8802
Slightly volatile
Current Ratio3.11.612.2797
Slightly volatile
Capex Per Share0.01.0E-41.0E-4
Slightly volatile
Debt To Assets5.535.272.7232
Slightly volatile
Days Of Payables Outstanding83.6 K106.4 K99.4 K
Slightly volatile
Ebt Per Ebit1.11.131.0448
Pretty Stable
Long Term Debt To Capitalization1.291.451.5841
Slightly volatile
Total Debt To Capitalization9.118.684.586
Slightly volatile
Quick Ratio3.11.612.2797
Slightly volatile
Cash Ratio2.851.442.1212
Slightly volatile
Debt Ratio5.535.272.7232
Slightly volatile

Dermata Therapeutics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap7.4 M7.8 M17.4 M
Slightly volatile
Enterprise Value588 K619 K7.9 M
Slightly volatile

Dermata Fundamental Market Drivers

About Dermata Therapeutics Financial Statements

Dermata Therapeutics investors use historical fundamental indicators, such as Dermata Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dermata Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue139.5 K124 K
Cost Of Revenue 289.80  275.31 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Dermata Stock Analysis

When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.